KOMBOGLYZE
2,5MG/850MG TBL FLM 14
| SÚKL code | 0193530 |
|---|---|
| Name of the product | KOMBOGLYZE |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | KOMBOGLYZE |
| Supplement | 2,5MG/850MG TBL FLM 14 |
| Strenght | 2,5MG/850MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 14 |
| Route | Oral use |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance |
METFORMIN HYDROCHLORIDE (METFORMINI HYDROCHLORIDUM) SAXAGLIPTINE HYDROCHLORIDE (SAXAGLIPTINI HYDROCHLORIDUM) |
| ATC group | A10BD10 |
| ATC group name | METFORMIN A SAXAGLIPTIN |
Marketing authorisation information
| Registration Number | EU/1/11/731/013 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | AstraZeneca AB, Södertälje |
| MA Holder country | ŠVÉDSKO |
cz